Rheumatology · Des Plaines, IL
NPI
1295850766
Since 2007
Specialty
Rheumatology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
150 N River Rd
Des Plaines, IL, 60016
Phone (847) 298-8470
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
191,513 services
Medicare patients, 2024
446
Average age 77
Drug cost, 2024
$1.6M
3,971 prescriptions
Company payments, 2025
$239
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David S Sager was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 94,004 times for 25 patients. In total David S Sager billed 191,513 services in 93 codes, and Medicare paid $1.7M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 94,004 | 25 | $3.61 | $339K |
| J3262 Injection, tocilizumab, 1 mg | Office | 38,600 | 11 | $4.69 | $181K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 12,360 | 37 | $24.84 | $307K |
| J0897 Injection, denosumab, 1 mg | Office | 8,751 | 86 | $20.42 | $179K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,160 | 19 | $0.11 | $122 |
| 99214 Office E&M - Established | Office | 1,083 | 423 | $85.53 | $93K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 868 | 382 | $11.23 | $9,747 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 844 | 69 | $0.52 | $436 |
| 36415 Venipuncture Blood Collection | Office | 832 | 391 | $2.96 | $2,463 |
| 85025 Blood Count | Office | 781 | 381 | $7.57 | $5,913 |
| 85651 Clinical Chemistry | Office | 779 | 385 | $4.17 | $3,247 |
| 86140 Clinical Chemistry | Office | 774 | 383 | $5.07 | $3,922 |
| 96372 Injection Administration | Office | 755 | 129 | $9.82 | $7,417 |
| 83735 Clinical Chemistry | Office | 747 | 378 | $6.53 | $4,882 |
| 80053 Clinical Chemistry | Office | 746 | 378 | $10.29 | $7,680 |
By year: 2022 $1.7M for 159,751 services; 2023 $1.6M for 164,409 services; 2024 $1.7M for 191,513 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 832 | 391 | $2.96 | $2,463 |
| 85025 Blood Count | 781 | 381 | $7.57 | $5,913 |
| 85651 Clinical Chemistry | 779 | 385 | $4.17 | $3,247 |
| 86140 Clinical Chemistry | 774 | 383 | $5.07 | $3,922 |
| 83735 Clinical Chemistry | 747 | 378 | $6.53 | $4,882 |
| 80053 Clinical Chemistry | 746 | 378 | $10.29 | $7,680 |
| 82610 Clinical Chemistry | 739 | 376 | $18.05 | $13K |
| 82306 Clinical Chemistry | 713 | 372 | $28.97 | $21K |
| 86235 Immunoassay | 605 | 98 | $17.43 | $11K |
| 86431 Immunoassay | 128 | 107 | $5.56 | $712 |
Medicare prescription drug claims, 2024
In 2024, the drug David S Sager prescribed most often to Medicare patients was Prednisone, with 667 prescriptions and refills. In total David S Sager wrote 3,971 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 667 | 1,448 | 197 | $7,789 |
| Celecoxib Generic | 365 | 840 | 103 | $9,800 |
| Methotrexate Methotrexate Sodium | 333 | 890 | 96 | $13K |
| Tramadol Hcl Generic | 252 | 276 | 60 | $2,383 |
| Hydroxychloroquine Sulfate Generic | 243 | 607 | 72 | $11K |
| Methylprednisolone Generic | 190 | 207 | 88 | $1,461 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 175 | 175 | 39 | $5,357 |
| Meloxicam Generic | 163 | 345 | 52 | $1,085 |
| Gabapentin Generic | 153 | 380 | 43 | $2,370 |
| Allopurinol Generic | 92 | 260 | 26 | $1,483 |
| Omeprazole Generic | 83 | 236 | 26 | $1,560 |
| Leflunomide Generic | 78 | 206 | 23 | $4,199 |
| Alprazolam Generic | 47 | 51 | Under 11 | $334 |
| Etodolac Generic | 46 | 83 | 17 | $2,117 |
| Enbrel Sureclick Etanercept | 45 | 64 | Under 11 | $505K |
Brand drugs: 188 claims; generic drugs: 3,783 claims; opioid claims: 463.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David S Sager $239 ($239 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $239.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 4 | $239 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.